Yeah. 2% to 4% percent organic sales growth and 0% to 2% from a reported is what we're expecting now. And that is slightly below what we want from a long-term perspective. But, just to put that in perspective, of course, if you look at our four-year CAGR and our strategy period, we did deliver in the midpoint of that range at 4% and again, 4% this year. This year coming up is a kind of a tale of two halves, is the way I would talk about it. And we expect stronger growth in the front half as we continue to lap the two price increases that we have. And then in the back half, we expect it to get tougher for consumers. And right now, our expectation is a mild recession. So when you put those things together, I think in aggregate, we feel good about the top-line that we've committed to. In addition, that includes about 1 point of a headwind from our vitamins, minerals, and supplements business. As we spoke about, over the last couple of calls, we have re-engineered that plan to focus more on profitability, and we've done that at a trade-off from a top-line perspective. So that does include a 1 point headwind. And, over time, we would expect that that wouldn't be the case and that, that would help us return to getting in within that 3% to 5%. The way that I would think about this, as we march through the year, we are expecting, again, lapping two price increases, we are expecting our elasticities to be more normalized as we go through the course of the year. We're expecting trade promotion to normalize as well, and then we're expecting a mild recession in the back half. Those are all of our assumptions in forming that growth. And if those come true, we feel this plan is a very balanced plan, but we'll be watching really carefully as we move through the year. If any one of those assumptions change, and we need to adjust our plan, that could impact both, on the high end and the lower end of us delivering against what we put out there from an outlook perspective.